SCHEMBL22983974

SCHEMBL22983974

O=C(OC[C@H]1O[C@H](n2ccc(=O)[nH]c2=O)[C@@H](OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.71
USP2 O75604 1/20 0.71
POLB P06746 1/20 0.71
KMT2A Q03164 1/20 0.71
GAPDH P04406 2/20 0.51
P2RY2 P41231 9/20 0.50
P2RY12 Q9H244 2/20 0.50
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
LMNA P02545 1/20 0.47
THRB P10828 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
SLC28A1 O00337 1/20 0.46
SLC28A2 O43868 1/20 0.46
SLC29A1 Q99808 1/20 0.46
SLC28A3 Q9HAS3 1/20 0.46
ALDH1A1 P00352 1/20 0.46
P2RY6 Q15077 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256521 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL7943170 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL9002154 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL22992612 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL9221115 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL23906728 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL19326815 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL10459898 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL22992319 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH
SCHEMBL2027546 1.00 MEN1 (0.71) MEN1USP2POLBKMT2AGAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159922-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2023-05-25 US disclosed
US-20230159922-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2023-05-25 US disclosed
US-20230159922-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2023-05-25 US disclosed
EP-4013428-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF Ionis Pharmaceuticals, Inc. (US) 2022-06-22 EP disclosed
WO-2021030763-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2021-02-18 WO disclosed